NexImmune Inc. (NASDAQ: NEXI) Investing Potential Is $1.28 – Marketing Sentinel
Home  »  Technologies   »  NexImmune Inc. (NASDAQ: NEXI) Investing Potential ...

NexImmune Inc. (NASDAQ: NEXI) Investing Potential Is $1.28

During the last session, NexImmune Inc. (NASDAQ:NEXI)’s traded shares were 0.12 million. At the end of the trading day, the stock’s price was $1.28, reflecting an intraday gain of 4.07% or $0.05. The 52-week high for the NEXI share is $18.78, that puts it down -1367.19 from that peak though still a striking 15.62% gain since the share price plummeted to a 52-week low of $1.08. The company’s market capitalization is $31.83M, and the average intraday trading volume over the past 10 days was 0.25 million shares, and the average trade volume was 1.19 million shares over the past three months.

NexImmune Inc. (NEXI) received a consensus recommendation of an Overweight from analysts. That translates to a mean rating of 2.00. NEXI has a Sell rating from 0 analyst(s) out of 4 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 2 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.68.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


NexImmune Inc. (NASDAQ:NEXI) trade information

NexImmune Inc. (NEXI) registered a 4.07% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 4.07% in intraday trading to $1.28 this Friday, 08/05/22, hitting a weekly high. The stock’s 5-day price performance is 11.30%, and it has moved by -26.86% in 30 days. Based on these gigs, the overall price performance for the year is -88.13%. The short interest in NexImmune Inc. (NASDAQ:NEXI) is 0.46 million shares and it means that shorts have 0.15 day(s) to cover.

The consensus price target of analysts on Wall Street is $7.00, which implies an increase of 81.71% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $4.00 and $12.00 respectively. As a result, NEXI is trading at a discount of -837.5% off the target high and -212.5% off the low.

NexImmune Inc. (NEXI) estimates and forecasts

Statistics show that NexImmune Inc. has underperformed its competitors in share price, compared to the industry in which it operates. NexImmune Inc. (NEXI) shares have gone down -52.42% during the last six months, with a year-to-date growth rate less than the industry average at -1.18% against 1.00. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to shrink -25.90% this quarter and then drop -7.70% in the quarter after that.

While earnings are projected to return -65.20% in 2022.

NEXI Dividends

NexImmune Inc. is due to release its next quarterly earnings between March 29 and April 04. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

NexImmune Inc. (NASDAQ:NEXI)’s Major holders

NexImmune Inc. insiders own 35.09% of total outstanding shares while institutional holders control 42.06%, with the float percentage being 64.79%. ArrowMark Colorado Holdings LLC is the largest shareholder of the company, while 80 institutions own stock in it. As of Mar 30, 2022, the company held over 1.33 million shares (or 5.81% of all shares), a total value of $5.58 million in shares.

The next largest institutional holding, with 1.2 million shares, is of Artal Group S.A.’s that is approximately 5.25% of outstanding shares. At the market price on Mar 30, 2022, these shares were valued at $5.05 million.

Also, the Mutual Funds coming in first place with the largest holdings of NexImmune Inc. (NEXI) shares are Fidelity Select Portfolios – Biotechnology and Vanguard Total Stock Market Index Fund. Data provided on May 30, 2022 indicates that Fidelity Select Portfolios – Biotechnology owns about 0.53 million shares. This amounts to just over 2.30 percent of the company’s overall shares, with a $1.2 million market value. The same data shows that the other fund manager holds slightly less at 0.19 million, or about 0.85% of the stock, which is worth about $0.82 million.

Leave a Comment

Your email address will not be published.

On Key

Related Posts